Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | MMP1 | P03956 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 1/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | MMP8 | P22894 | 1/20 | 0.57 |
| ▸ | MMP13 | P45452 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8486571 | 0.88 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2MAPTGAACA1 | |
| SCHEMBL23345377 | 0.83 | ALDH1A1 (0.67) | ALDH1A1SMN1; SMN2MAPTCA1CA2 | |
| SCHEMBL15840367 | 0.83 | ALDH1A1 (0.67) | ALDH1A1SMN1; SMN2MAPTCA1CA2 | |
| SCHEMBL15199346 | 0.82 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2MAPTGAACA1 | |
| SCHEMBL2408403 | 0.81 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2MAPTCA1CA2 | |
| SCHEMBL1479992 | 0.81 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2MAPTCA1CA2 | |
| SCHEMBL2333640 | 0.81 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2MAPTGAACA1 | |
| SCHEMBL4781214 | 0.81 | CA1 (0.61) | ALDH1A1SMN1; SMN2MAPTCA1CA2 | |
| SCHEMBL12169369 | 0.81 | ALDH1A1 (0.68) | ALDH1A1SMN1; SMN2MAPTCA1CA2 | |
| SCHEMBL3834643 | 0.81 | ALDH1A1 (0.80) | ALDH1A1SMN1; SMN2MAPTCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 285 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543865-B1 | PROCESS FOR PREPARING SOLKETAL ACRYLATE BY TRANSESTERIFICATION | BASF SE (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260008742-A1 | CONTINUOUS PROCESS FOR PRODUCING N-BUTYL (METH)ACRYLATE WITH A CATALYST RECIRCULATION SYSTEM | BASF SE (DE) | 2026-01-08 | — | — | US | disclosed |
| US-20250257026-A1 | CONTINUOUS METHOD FOR PRODUCING N-BUTYL(METH)ACRYLATE INCLUDING A CATALYST RECIRCULATION PROCESS | BASF SE (DE) | 2025-08-14 | — | — | US | disclosed |
| EP-4568764-A1 | INTEGRATION OF A HEAT PUMP CIRCUIT IN A DISTILLATION PLANT FOR POLYMERISABLE SUBSTANCES | BASF SE (DE) | 2025-06-18 | — | — | EP | disclosed |
| EP-4568938-A1 | CONTINUOUS METHOD FOR PRODUCING N-BUTYL(METH)ACRYLATE INCLUDING A CATALYST RECIRCULATION PROCESS | BASF SE (DE) | 2025-06-18 | — | — | EP | disclosed |
| EP-4568939-A1 | CONTINUOUS PROCESS FOR PRODUCING N-BUTYL (METH)ACRYLATE WITH A CATALYST RECIRCULATION SYSTEM | BASF SE (DE) | 2025-06-18 | — | — | EP | disclosed |
| US-12290768-B2 | Device for carrying out material exchange processes | BASF SE (DE) | 2025-05-06 | — | — | US | disclosed |
| CN-119677711-A | Continuous process for preparing n-butyl (meth) acrylate with catalyst reflux | 巴斯夫欧洲公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119654307-A | Continuous process for preparing n-butyl (meth) acrylate with catalyst reflux | 巴斯夫欧洲公司 | 2025-03-18 | — | — | CN | disclosed |
| US-20250074859-A1 | PROCESS FOR THE CONTINUOUS DISTILLATION OF ACRYLATES | BASF SE (DE) | 2025-03-06 | — | — | US | disclosed |
| WO-2004104050-A1 | METHOD FOR THE PRODUCTION, TREATMENT AND FURTHER PROCESSING OF POLYMERISABLE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-02 | — | — | WO | disclosed |
| US-20040147772-A1 | Preparation of (meth)acrylic esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-07-29 | — | — | US | disclosed |
| US-20040082737-A1 | Determination of the amount of polymer deposited from (meth) acrylic acid and/or (meth) acrylic esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-29 | — | — | US | disclosed |
| EP-0814381-B1 | Positive image forming composition | FUJI PHOTO FILM CO LTD (JP) | 2001-09-19 | — | — | EP | disclosed |
| EP-0814381-A1 | Positive image forming composition | FUJI PHOTO FILM CO., LTD. (JP) | 1997-12-29 | — | — | EP | disclosed |
| US-5160363-A | For sugarbeets | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-11-03 | — | — | US | disclosed |
| EP-0422031-A1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-04-17 | — | — | EP | disclosed |
| WO-1989010921-A1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-11-16 | — | — | WO | disclosed |
| WO-1987007606-A1 | HERBICIDAL SULFONAMIDES | DU PONT (US) | 1987-12-17 | — | — | WO | disclosed |
| US-4479901-A | Fluorination of carbanions with N-fluoro-N-alkylsulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008742-A1 | CONTINUOUS PROCESS FOR PRODUCING N-BUTYL (METH)ACRYLATE WITH A CATALYST RECIRCULATION SYSTEM | MMAB, ALKBH1, ALKBH3 | ALDH1A1 134/4885SMN1; SMN2 806/4885MAPT 3060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.